AstraZeneca Secures CDSCO Approval to Import SZC for Hyperkalaemia

The Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, has granted AstraZeneca Pharma India permission to import pharmaceutical formulations of new drugs for sale or distribution of oral

Wipro Unveils AI-Enabled Ultrasound System for Enhanced Clinical Care in India

Wipro GE Healthcare has launched the Versana Premier R3. This is an AI-enabled ultrasound system designed to enhance...

Zydus Lifesciences Enhances Transplant Outcomes with Innovative Therapy

The Indian pharmaceutical sector is witnessing a major advance. Zydus Lifesciences is launching ANVIMO, a cost-effective substitute for the prevention of Cytomegalovirus (CMV) disease in haematopoietic stem cell transplant (HSCT) and kidney transplan

CDSCO Introduces Online Registration for Clinical Research Organizations

In anticipation of the mandated registration of clinical research organizations (CROs) starting next month, the Central Drug Regulator has set up the Sugam portal to facilitate online registration of the enterprises.

Glenmark Pharmaceuticals Rises 3.49% for Third Consecutive Session

Glenmark Pharmaceuticals Ltd's share price is trading at Rs 1380.8, up 3.49% on the day as of 12:49 eastern standard time on NSE. The stock has arisen significantly in the past...

India to Release OTC Drug List This Month, Ensuring Public Health Safety

India to finalize a report this month on the list of drugs to be switched from prescription-based to OTC status. The subcommittee formed to review...

Senores Pharma Acquires 14 ANDAs from Dr. Reddy's for US Market Expansion

Senores Pharmaceuticals, based out of Gujarat, signed a memorandum of understanding with Dr Reddy's Laboratories regarding the sale of 14...

CDSCO Approves AstraZeneca's Durvalumab for Liver Cancer Therapy

AstraZeneca Pharma India Ltd has received the approval from the Central Drugs Standard Control Organisation (CDSCO) to launch and import its cancer treatment Durvalumab (Imfinzi) in India. In a regulatory filing, the company noted that the approval i

Zydus to Launch World's First Combo Vaccine for Shigellosis & Typhoid

Zydus Lifesciences Limited declared its intention to concentrate on creating a vaccine that covers both typhoid and shigellosis.

India, Vietnam Strengthen Ties in Pharmaceutical Trade and Collaboration

A total of 39 Indian pharmaceutical firms engaged with over 50 Vietnamese partners, participating in productive discussions at an ‘India-Vietnam Business-to-Business (B2B)’ meeting focused on the pharmaceutical sector...

© 2025 India Pharma Outlook. All Rights Reserved.